Particle Therapy Market Size, Revenue, Business Growth Statistics And Analysis Report 2019-2027

                                                                             

              Particle Therapy Market

  Particle Therapy is a type of external beam radiotherapy that uses an intense proton and neutron beam. Hadron treatment is another name for it. Particle therapy is a type of cancer treatment that involves directing intense ionising particles at the tumour site. Particle treatment causes damage to cells' DNA, resulting in cell death.

Particle therapy's market growth is being aided by factors such as its high degree of precision, lesser side effects, and quicker treatment time as compared to conventional therapy. Furthermore, the expansion of the Particle Therapy Market is being fueled by an increase in research funding, an increase in particle therapy facilities, and an increase in the number of cancer patients and clinical trials. Limited insurance coverage for particle therapy and unfavourable reimbursement policies, on the other hand, are limiting the market's expansion. Nonetheless, a surge in developing-country adoption and the acceptance of pencil-beam scanning will present a promising chance for particle therapy in the next years.

Market Segmentation:

On the basis of product

• Synchrotron

• Cyclotron

On the basis of type

• Heavy Ion

• Proton Therapy

On the basis of application

• Breast Cancer

• Brain Cancer

• Prostate Cancer

• Lung Cancer

• Others

On the basis of end user

• Hospital

• Clinics

• Ambulatory Surgery Centers

• Others

The high cost of particle therapy treatment for cancer is a major stumbling block to the market's expansion. Proton therapy, for example, costs anything from US$ 30,000 to US$ 120,000 in 2017. A course of radiosurgery treatment, on the other hand, costs between $8,000 and $12,000. As a result of the high cost of cancer treatment using particle therapy, demand for particle therapy over conventional radiation therapy is likely to be minimal.

Some of the key players operating in the global particle therapy market include Ion Beam Applications, Provision Healthcare, Mevion Medical Systems, Inc., Optivus Proton Therapy, Inc., ProTom International, Inc., Advanced Oncotherapy Plc., Varian Medical Systems, Inc., Hitachi, Ltd., Danfysik A/S, Provision Healthcare, LLC, and IBA Worldwide.